Select a Region
North America

Browsing Archive: Scientific InsightsScientific Insights | EVERSANA - Part 2

EVERSANA
Posted on 9월 25, 20239/25/23

PO206 Indirect Treatment Comparisons Of The Gene Therapy Etranacogene Dezaparvovec (CSL222) Vs. Extended Half-life Factor Ix Therapies For Severe Or Moderately Severe Haemophilia B

EVERSANA
Posted on 9월 25, 20239/25/23

Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis

EVERSANA
Posted on 9월 25, 20239/25/23

Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal Spray for Diabetic Gastroparesis (DGP)

EVERSANA
Posted on 9월 25, 20239/25/23

Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review

EVERSANA
Posted on 9월 25, 20239/25/23

Strengths and Limitations of Different Costing Approaches used for Hospital Budget Impact Models: Application to Imaging Guidance in LAAO Procedures.

EVERSANA
Posted on 9월 25, 20239/25/23

Use of Real-World Data for Hard-to-Identify Patient Population: Methodology and a Case Study 

EVERSANA
Posted on 9월 25, 20239/25/23

Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review.

EVERSANA
Posted on 9월 20, 20239/20/23

A Systematic Literature Review and Network Meta-Analysis of Therapies for Psoriatic Arthritis on Patient-reported Outcomes

EVERSANA
Posted on 9월 20, 20239/20/23

Comparative efficacy of therapies for relapsing multiple sclerosis: a systematic review and network meta-analysis

EVERSANA
Posted on 9월 20, 20239/20/23

An improved definition and SAFE Rule for Predicting Difficult Intravascular Access (DIVA) in Hospitalized Adults

Scientific Insights